Loading organizations...
§ Private Profile · Cambridge, MA, USA
Provides advanced sweat-sensing wearables for real-time biomarker insights in health, performance, wellness, industrial safety.
Based in Cambridge, Massachusetts, Epicore Biosystems develops advanced sweat-sensing wearables and cloud analytics platforms that monitor hydration, electrolytes, and other physiological biomarkers in real-time. The company produces soft, non-invasive microfluidic devices designed to capture continuous, clinical-grade health data for applications across digital health, sports performance, wellness, and industrial safety environments. Originally spun out of research conducted at Northwestern University, the enterprise currently licenses its proprietary biowearable technology to Fortune 500 corporations and major government entities, including Gatorade, PepsiCo, and the Department of Defense. In January 2024, the firm secured undisclosed strategic venture capital investments from Pegasus Tech Ventures and Denka Company Limited to expand its personalized hydration and wellness monitoring operations throughout the broader Asian market. Epicore Biosystems was officially founded in the year 2017 by co-founders Roozbeh Ghaffari, AJ Aranyosi, and John A. Rogers.
Epicore Biosystems has raised $16.0M across 2 funding rounds.
Epicore Biosystems has raised $16.0M in total across 2 funding rounds.
Epicore Biosystems has raised $16.0M across 2 funding rounds. Most recently, it raised $6.0M Series B in April 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 1, 2025 | $6M Series B | JOE Exner | Alumni Ventures, IA Capital Group, Markd VC, Social Starts, Bascom Ventures, Mike Edelhart, David Beazley | Announced |
| Feb 1, 2022 | $10M Series A | — | Alumni Ventures, Drive Capital, Innovation Endeavors | Announced |
Epicore Biosystems is a digital health company developing advanced sweat-sensing biowearables that analyze sweat biomarkers for real-time insights into hydration, stress, nutrition, and metabolic health.[1][2][4] Their flagship product, Connected Hydration, serves industrial workers, elite athletes, sports teams, clinical researchers, and consumers by monitoring sweat composition, electrolytes, skin temperature, motion, and thermal flux to deliver personalized haptic alerts and cloud-based recommendations, preventing dehydration, fatigue, and heat stress.[3][4][6] Clinically validated and deployed globally with partners like Chevron, PepsiCo, Gatorade, United Airlines, the U.S. military, and professional sports leagues (NBA, NFL, MLB), the company has raised $36.5M in funding, including a $32M Series B in 2025, signaling strong growth momentum toward enterprise expansion in industrial markets like energy, construction, and aviation.[2][3]
Founded in 2018 in Cambridge, Massachusetts, Epicore Biosystems emerged from over two decades of microfluidic and soft materials research in Prof. John Rogers' Laboratory at Northwestern University's Center for Bio-Integrated Electronics.[5] Co-founders Roozbeh Ghaffari, PhD (CEO), AJ Aranyosi, PhD (Chief Digital Officer), and Stephen Lee (Chief Technology Officer) leveraged their expertise in biomedical engineering, data science, and material science to commercialize "skin-like" sweat-sensing platforms.[1][5] Early traction came from deployments with professional sports teams, military labs (U.S. Air Force, Office of Naval Research, U.S. Army), and clinical studies on stroke, skin health, stress, fatigue, and kidney health, culminating in partnerships with Fortune 500 companies and a pivotal $26M Series B in early 2025, expanded to $32M.[2][3][5]
Epicore rides the wearable health tech boom, capitalizing on non-invasive sweat analysis to decode metabolic signals amid rising demand for real-time worker safety and performance optimization in high-risk sectors like energy, manufacturing, and sports.[3][4][6] Timing aligns with post-pandemic focus on heat stress prevention—exacerbated by climate change—and enterprise adoption of biosensors, as seen in pilots with Chevron, Bechtel, and Gatorade.[3] Market forces like regulatory pushes for industrial safety (e.g., DoD contracts) and athlete personalization favor Epicore's clinically backed, haptic-feedback edge over competitors, influencing the ecosystem by pioneering sweat as a biomarker source for AI-driven health platforms.[2][3][5]
Epicore is poised to dominate sweat-based biowearables with its $32M Series B fueling global expansion into Australia, the Middle East, Asia, and new biomarkers for kidney health and stress management.[3] Trends like AI-enhanced cloud analytics, enterprise wellness mandates, and climate-driven heat risks will accelerate adoption, potentially evolving Epicore into a metabolic health platform leader. As sweat unlocks "actionable insights for all," from workers to consumers, Epicore's scientist-built innovations promise to redefine accessible digital health.[1][4]
Epicore Biosystems has raised $16.0M in total across 2 funding rounds.
Epicore Biosystems's investors include Joe Exner, Alumni Ventures, IA Capital Group, Markd VC, Social Starts, Mike Edelhart, David Beazley, Drive Capital, Innovation Endeavors.